Induction of the C-terminal proteolytic cleavage of AβPP by statins

Journal of Alzheimer's Disease

Volumn 25, Issue 1, 2011, Pages 51-57

  Descamps, Olivier ^a   Zhang, Qiang ^a   John, Varghese ^a   Bredesen, Dale E ^a,b  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AlphaLisa assay; A PPneo fragment; caspase cleavage; C 31; D664; Jcasp; statins

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ATORVASTATIN; CERIVASTATIN; COMPACTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CHO CELL; CONTROLLED STUDY; DRUG PENETRATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE;

EID: 79959633548     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-101857     Document Type: Article

References (35)

1. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, Salvesen GS,Koo EH, BredesenDE(2000)Asecond cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 6, 397-404. (Pubitemid 30208156)
2. Bredesen DE (2009) Neurodegeneration in Alzheimer's disease: Caspases and synaptic element interdependence. Mol Neurodegener 4, 27.
3. Shaked GM, Kummer MP, Lu DC, Galvan V, Bredesen DE, Koo EH (2006) Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J 20, 1254-1256.
4. Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, Schubert-Zsilavecz M, Karas M, Muller WE, Wood WG (2005) Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther 312, 786-793. (Pubitemid 40189580)
5. Vuletic S, Riekse RG, Marcovina SM, Peskind ER, Hazzard WR, Albers JJ (2006) Statins of different brain penetrability differentially affect CSF PLTP activity. Dement Geriatr Cogn Disord 22, 392-398. (Pubitemid 44726008)
6. Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER (2006) Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J Alzheimers Dis 10, 399-406.
7. Botti RE, Triscari J, Pan HY, Zayat J (1991) Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin Neuropharmacol 14, 256-261.
8. Saheki A, Terasaki T, Tamai I, Tsuji A (1994) In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res 11, 305-311. (Pubitemid 24076229)
9. Lu DC, Shaked GM, Masliah E, Bredesen DE,Koo EH(2003) Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann Neurol 54, 781-789. (Pubitemid 37504953)
10. Bredesen DE, Rao RV, Mehlen P (2006) Cell death in the nervous system. Nature 443, 796-802. (Pubitemid 44622684)
11. Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo EH, Bredesen DE (2002) Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem 82, 283-294. (Pubitemid 34774619)
12. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K, Greenberg DA, Bredesen DE (2006) Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci U S A 103, 7130-7135.
13. Park SA, Shaked GM, Bredesen DE, Koo EH (2009) Mechanism of cytotoxicity mediated by the C31 fragment of the amyloid precursor protein. Biochem Biophys Res Commun 388, 450-455.
14. Goldstein JL, Brown MS (2001) Molecular medicine. The cholesterol quartet. Science 292, 1310-1312.
15. Miserez AR, Muller PY, Barella L, Barella S, Staehelin HB, Leitersdorf E, Kark JD, Friedlander Y (2002) Sterolregulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia. Atherosclerosis 164, 15-26. (Pubitemid 34765633)
16. Pedersen TR, OlssonAG, Faergeman O, Kjekshus J,Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyorala K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ (1998) Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 97, 1453-1460. (Pubitemid 28191300)
17. Tanaka K, Asanuma M, Ogawa N (2004) Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells. Neurochem Res 29, 1529-1536. (Pubitemid 38860234)
18. Ongini E, Impagnatiello F, Bonazzi A, Guzzetta M, Govoni M, Monopoli A, Del Soldato P, Ignarro LJ (2004) Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties. Proc Natl Acad Sci U S A 101, 8497-8502. (Pubitemid 38736603)
19. Kwak B, Mulhaupt F, Myit S, Mach F (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6, 1399-1402. (Pubitemid 32001026)
20. Gibson Wood W, Eckert GP, Igbavboa U, Muller WE (2003) Amyloid beta-protein interactions with membranes and cholesterol: Causes or casualties of Alzheimer's disease. Biochim Biophys Acta 1610, 281-290. (Pubitemid 36324471)
21. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, SmallGW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
22. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer's disease: The cholesterol connection. Nat Neurosci 6, 345-351. (Pubitemid 36373979)
23. Vollmer T, Key L, Durkalski V, TyorW, Corboy J, Markovic- Plese S, Preiningerova J, Rizzo M, Singh I (2004) Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet 363, 1607-1608. (Pubitemid 38625664)
24. Vaughan CJ, Delanty N (1999) Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30, 1969-1973. (Pubitemid 29411843)
25. Carlsson CM, Gleason CE, Johnson SC, Xu G, Huang Y, Barnet J, Fain S, Blazel H, Henrik Z, Kaj B, Hermann BP, Dowling NM, Newman GC, Puglielli L, Atwood CS, RowleyH, Sager M, Asthana S (2010)Arandomized, doubleblind placebo-controlled trial of simvastatin on CSF, MRI, and cognitive biomarkers in middle-aged adults at risk for Alzheimer's disease: The ESPRIT Study. Alzheimers Dement 6, S151-S152.
26. Pavlov OV, Bobryshev Yu V, Balabanov Yu V, Ashwell K (1995) An in vitro study of the effects of lovastatin on human fetal brain cells. Neurotoxicol Teratol 17, 31-39.
27. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357. (Pubitemid 33063104)
28. Shin Y-K (2009) Cholesterol, statins, and brain function: A hypothesis from a molecular perspective. IBC 1, 2.
29. Jeppesen U, Gaist D, Smith T, Sindrup SH (1999) Statins and peripheral neuropathy. Eur J Clin Pharmacol 54, 835-838. (Pubitemid 29051327)
30. Gaist D, Jeppesen U, Andersen M, Garcia Rodriguez LA, Hallas J, Sindrup SH (2002) Statins and risk of polyneuropathy: A case-control study. Neurology 58, 1333-1337. (Pubitemid 34507158)
31. Staffa JA, Chang J, Green L (2002) Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 346, 539-540.
32. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM (2003) Statin-associated memory loss: Analysis of 60 case reports and review of the literature. Pharmacotherapy 23, 871-880. (Pubitemid 36875671)
33. Kotti TJ, Ramirez DM, Pfeiffer BE, Huber KM, Russell DW (2006) Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci U S A 103, 3869-3874. (Pubitemid 43376647)
34. Swistowski A, Zhang Q, Orcholski ME, Crippen D, Vitelli C, Kurakin A, Bredesen DE (2009) Novel mediators of amyloid precursor protein signaling. J Neurosci 29, 15703-15712.
35. Galvan V, Logvinova A, Sperandio S, Ichijo H, Bredesen DE (2003) Type 1 insulin-like growth factor receptor (IGFIR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem 278, 13325-13332. (Pubitemid 36800104)